Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patientâs back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
äŒæ¥ã³ãŒãCHEK
äŒç€ŸåCheck Cap Ltd
äžå Žæ¥Feb 19, 2015
æé«çµå¶è²¬ä»»è
ãCEOãOvadia (Alex)
åŸæ¥å¡æ°- -
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Feb 19
æ¬ç€Ÿæåšå°29 Abba Hushi Ave.
éœåž
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœIsrael
éµäŸ¿çªå·3009000
é»è©±çªå·97248303401
ãŠã§ããµã€ãhttps://check-cap.com/
äŒæ¥ã³ãŒãCHEK
äžå Žæ¥Feb 19, 2015
æé«çµå¶è²¬ä»»è
ãCEOãOvadia (Alex)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã